FARN

Faron Pharmaceuticals Oy
FARN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
£226.71M
EV
£228.87M
Shares Outstanding
112.05M
Beta
1.18

Wall Street View

Analyst Rating
BUY
Analyst Target Price
£11.94
P/E 2024E
-
P/Revenue 2024E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Faron Pharmaceuticals Oy

gainify
FARN

Faron Pharmaceuticals Oy

FARN

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company’s lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or is...

Sector

Healthcare

Industry

Biotechnology

CEO

Jalkanen, Juho

Employees

25

IPO Date

2015-11-17

Headquarters

Joukahaisenkatu 6 B, Turku, Finland Proper, 20520, Finland

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.